Cargando…

Preclinical Development of ONC1-13B, Novel Antiandrogen for Prostate Cancer Treatment

Recently new drugs targeting androgen-dependent axis have been approved for the treatment of castration-resistant prostate cancer (CRPC) - Zytiga and Xtandi (formerly MDV3100), several other candidates (for example, ARN-509) are in early phases of clinical trials. However despite significant improve...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ivachtchenko, Alexandre V., Mitkin, Oleg D., Kudan, Elizaveta V., Rjahovsky, Alexey A., Vorobiev, Anton A., Trifelenkov, Andrey S., Shevkun, Natalia A., Proskurina, Oxana V., Kravchenko, Dmitry V., Karapetian, Ruben N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2014
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3909768/ https://www.ncbi.nlm.nih.gov/pubmed/24494031 http://dx.doi.org/10.7150/jca.7773

Ejemplares similares

Crystal structure, Hirshfeld analysis and a molecular docking study of a new inhibitor of the Hepatitis B virus (HBV): ethyl 5-methyl-1,1-dioxo-2-{[5-(pentan-3-yl)-1,2,4-oxadiazol-3-yl]methyl}-2H-1,2,6-thiadiazine-4-carboxylate
por: Ivachtchenko, Alexandre V., et al.
Publicado: (2020)

The Efficacy of Aprotinin Combinations with Selected Antiviral Drugs in Mouse Models of Influenza Pneumonia and Coronavirus Infection Caused by SARS-CoV-2
por: Ivashchenko, Andrey A., et al.
Publicado: (2022)

Synthesis, X-ray crystal structure, Hirshfeld surface analysis, and molecular docking study of novel inhibitor of hepatitis B: methyl 4-fluoro-3-(morpholinosulfonyl)benzo[b]thiophene-2-carboxylate
por: Ivachtchenko, Alexandre V., et al.
Publicado: (2019)

Effect of Aprotinin and Avifavir(®) Combination Therapy for Moderate COVID-19 Patients
por: Ivashchenko, Andrey A., et al.
Publicado: (2021)

Physicochemical Profile of Antiandrogen Drug Bicalutamide: Solubility, Distribution, Permeability
por: Volkova, Tatyana V., et al.
Publicado: (2022)

Second-Generation Antiandrogens: From Discovery to Standard of Care in Castration Resistant Prostate Cancer
por: Rice, Meghan A., et al.
Publicado: (2019)

Synthesis of Prostate-Specific Membrane Antigen-Targeted Bimodal Conjugates of Cytotoxic Agents and Antiandrogens and Their Comparative Assessment with Monoconjugates
por: Zyk, Nikolai Y., et al.
Publicado: (2023)

Potentially Biodynamic Tetraaza Macrocycles and their Manganese Complexes: Antiandrogen, Antimicrobial and PDI Studies
por: Chaudhary, Ashu, et al.
Publicado: (2005)

AVIFAVIR for Treatment of Patients With Moderate Coronavirus Disease 2019 (COVID-19): Interim Results of a Phase II/III Multicenter Randomized Clinical Trial
por: Ivashchenko, Andrey A, et al.
Publicado: (2020)

‘ANTIANDROGENIC PROPERTIES OF NEEM SEED OIL (AZADIRACHTA INDICA) IN MALE RAT AND RABBI’
por: Sharma, J. D., et al.
Publicado: (1987)

Designer antiandrogens join the race against drug resistance
por: Josan, Jatinder S, et al.
Publicado: (2013)

Antiandrogen and Antimicrobial Aspects of Coordination Compounds of Palladium(II), Platinum(II) and Lead(II)
por: Singh, R. V., et al.
Publicado: (2001)

Glucocorticoid Receptor Binding Inhibits an Intronic IL33 Enhancer and is Disrupted by rs4742170 (T) Allele Associated with Specific Wheezing Phenotype in Early Childhood
por: Gorbacheva, Alisa M., et al.
Publicado: (2018)

Rational Second-Generation Antiandrogen Use in Prostate Cancer
por: Orme, Jacob J, et al.
Publicado: (2022)

The Risk G Allele of the Single-Nucleotide Polymorphism rs928413 Creates a CREB1-Binding Site That Activates IL33 Promoter in Lung Epithelial Cells
por: Gorbacheva, Alisa M., et al.
Publicado: (2018)

Advantage of soybean isoflavone as antiandrogen on acne vulgaris
por: Riyanto, Puguh, et al.
Publicado: (2015)

Combining Antiandrogens with Immunotherapy for Bladder Cancer Treatment
por: Besançon, Marjorie, et al.
Publicado: (2022)

Aprotinin—Drug against Respiratory Diseases
por: Ivachtchenko, Alexandre V., et al.
Publicado: (2023)

Once-daily medications for the pharmacological management of ADHD in adults
por: Tcheremissine, Oleg V, et al.
Publicado: (2009)

Antiandrogenic treatment of obsessive compulsive neurosis: A case review
por: Huerga García, L., et al.
Publicado: (2023)

Overcoming mutation-based resistance to antiandrogens with rational drug design
por: Balbas, Minna D, et al.
Publicado: (2013)

Reversing resistance to antiandrogens with a histone deacetylase inhibitor
por: Ferrari, Anna C.
Publicado: (2018)

Resistance to Antiandrogens in Prostate Cancer: Is It Inevitable, Intrinsic or Induced?
por: Maitland, Norman J.
Publicado: (2021)

Use of Antiandrogens as Therapeutic Agents in COVID-19 Patients
por: Giotis, Efstathios S., et al.
Publicado: (2022)

Clusterin Is a Potential Lymphotoxin Beta Receptor Target That Is Upregulated and Accumulates in Germinal Centers of Mouse Spleen during Immune Response
por: Afanasyeva, Marina A., et al.
Publicado: (2014)

The A Allele of the Single-Nucleotide Polymorphism rs630923 Creates a Binding Site for MEF2C Resulting in Reduced CXCR5 Promoter Activity in B-Cell Lymphoblastic Cell Lines
por: Mitkin, Nikita A., et al.
Publicado: (2016)

p53-dependent expression of CXCR5 chemokine receptor in MCF-7 breast cancer cells
por: Mitkin, Nikita A., et al.
Publicado: (2015)

Preclinical Characterization of Once Weekly Basal Insulin Fc (BIF)
por: Moyers, Julie S, et al.
Publicado: (2021)

Methylation of Methyl 4-Hydroxy-2-thioxo-1,2-dihydroquinoline-3-carboxylate: Synthetic, Crystallographic, and Molecular Docking Studies
por: Kovalenko, Sergiy M., et al.
Publicado: (2020)

Preclinical Orthostatic Abnormalities May Predict Early Increase in Vascular Stiffness in Different Age Groups: A Pilot Study
por: Dorogovtsev, Victor N., et al.
Publicado: (2023)

Lipid catabolism inhibition sensitizes prostate cancer cells to antiandrogen blockade
por: Flaig, Thomas W., et al.
Publicado: (2017)

Antiandrogenic activity and metabolism of the organophosphorus pesticide fenthion and related compounds.
por: Kitamura, Shigeyuki, et al.
Publicado: (2003)

Persistent genital arousal disorder: Successful treatment with leuprolide (antiandrogen)
por: Deka, Kamala, et al.
Publicado: (2015)

Resistance to second generation antiandrogens in prostate cancer: pathways and mechanisms
por: Verma, Shiv, et al.
Publicado: (2020)

AVN-101: A Multi-Target Drug Candidate for the Treatment of CNS Disorders
por: Ivachtchenko, Alexandre V., et al.
Publicado: (2016)

MODL-06. PRECLINICAL EFFICACY OF THE IMIPRIDONE ONC-206 AGAINST MEDULLOBLASTOMA
por: Malhotra, Anshu, et al.
Publicado: (2020)

High intratumoral dihydrotestosterone is associated with antiandrogen resistance in VCaP prostate cancer xenografts in castrated mice
por: Huhtaniemi, Riikka, et al.
Publicado: (2022)

Chemoprevention of prostate cancer: Natural compounds, antiandrogens, and antioxidants – In vivo evidence
por: Özten-Kandaş, Nur, et al.
Publicado: (2011)

Enzalutamide as a second generation antiandrogen for treatment of advanced prostate cancer
por: Semenas, Julius, et al.
Publicado: (2013)

Resistance to Novel Antiandrogen Therapies in Metastatic Castration-Resistant Prostate Cancer
por: Boudadi, Karim, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_g3dsknpvjdl1daftolr2q76cb0